semaglutide and hidradenitis suppurativa semaglutide - Impact ofsemaglutideuse in obeseanddiabetic patients withhidradenitis suppurativa People with hidradenitis suppurativa (HS) who have overweight or obesity Semaglutide and Hidradenitis Suppurativa: A Promising Avenue for Symptom Management

Mounjarohidradenitis suppurativa Hidradenitis suppurativa (HS), a chronic inflammatory skin condition, presents a significant challenge for individuals seeking effective management strategies. Characterized by painful nodules, abscesses, and scarring, HS can profoundly impact quality of life. Recent research has illuminated a potential new therapeutic avenue: semaglutideSemaglutide for weight loss in obese patients as an .... Originally developed for type 2 diabetes and weight management, semaglutide, a GLP-1 receptor agonist, is showing promising results in alleviating HS symptoms, particularly in patients with obesity and hidradenitis suppurativa.

The scientific community is increasingly exploring the role of semaglutide in dermatological applications. Studies are investigating how this medication might influence the inflammatory pathways involved in HS. Preliminary findings suggest that semaglutide may not only aid in weight management in people with obesity but also directly contribute to reducing the burden of HS.2025年8月20日—Glucagon-like peptide-1 receptor agonistsmay offer a new lifeline for patients with hidradenitis suppurativa, according to researchers. This dual benefit is particularly significant, as obesity is often a comorbidity that exacerbates HS2025年8月4日—Semaglutide Use for Decreasing Hidradenitis SuppurativaResource Utilization: A Retrospective Cohort Study Utilizing TriNetX · November 2024 ....

Evidence from various studies indicates that semaglutide treatment significantly improved quality of life for individuals experiencing hidradenitis suppurativaSemaglutide shows promise in treating hidradenitis .... A key observation is the potential for semaglutide to reduce the frequency and severity of HS flares. This is a crucial development, as frequent flares can lead to significant pain, disfigurement, and psychological distress. In some instances, patients have reported an extreme reduction of HS sores/open wounds, suggesting a notable impact on disease activityGLP-1s Show Promise for Patients With Hidradenitis Suppurativa and .... Furthermore, some individuals taking semaglutide have personally attested to significant improvements, with one patient stating, "Mine have been soooooo much better作者：D Lyons·2024·被引用次数：25—Semaglutide for weight loss in people with obesityas an adjunctive treatment for hidradenitis suppurativa: its impact on disease control .... I've been on it since April and it's helping so much it's insane."

The mechanism by which semaglutide exerts its effects on HS is still under investigation, but its anti-inflammatory properties are thought to play a pivotal role.2024年10月1日—This study offers preliminary evidence ofsemaglutide's potential role in reducing symptomsand improving quality of life for affected patients. By potentially decreasing inflammation, semaglutide, a GLP-1 receptor agonist, may help to calm the underlying disease processes driving HS. This is leading researchers to believe that GLP1-RAs may also offer therapeutic benefits in managing hidradenitis suppurativa.

Several studies are specifically examining the impact of semaglutide use in obese and diabetic patients with hidradenitis suppurativa.Wanted to share an unexpected positive side effect from Wegovy/semaglutide that I have been experiencing-extreme reduction of HS sores/open wounds. These investigations aim to quantify the extent of improvement in disease control and overall well-being. Research suggests that semaglutide can significantly improve outcomes for obese patients with hidradenitis suppurativa, contributing to better disease management.作者：M Hill·2025—Conclusion: The results suggest that HS patients on semaglutide demonstrate reduced HS severity. When semaglutide is added to standard hidradenitis suppurativa (HS) treatments, it appears to enhance their efficacy, leading to improved patient experiences.

Specifically, semaglutide was shown to reduce hidradenitis suppurativa flares and contribute to a better quality of life. The medication has also appeared to help patients with both weight management and HS symptoms.2024年9月25日—Semaglutide was shown to reduce hidradenitis suppurativa flaresin patients with obesity, according to a study presented at the European Academy of Dermatology ... This comprehensive approach, addressing both systemic weight and localized skin inflammation, is a significant advancement.GLP-1s Show Promise for Patients With Hidradenitis ... The findings suggest that semaglutide may reduce hidradenitis suppurativa flare-ups, offering a new ray of hope for individuals struggling with this condition.

The therapeutic potential of semaglutide extends beyond just symptom reduction. Studies are evaluating its broader impact on disease control and overall patient well-being. The positive outcomes observed indicate that semaglutide's potential role in reducing symptoms is multifaceted. For people with hidradenitis suppurativa (HS) who have overweight or obesity, Tirzepatide and Wegovy (which contains semaglutide) are emerging as potential adjunctive treatmentsMine have been soooooo much better. I've been on it since April and it's helping so much it's insane.|I didnt get any when taking it but ....

The growing body of evidence suggests that semaglutide improves hidradenitis suppurativa in patients with obesity. This includes improvements in quality of life and a reduction in the severity of the condition. By adding semaglutide to standard hidradenitis suppurative therapies, clinicians are observing tangible benefits for their patients. The impact of semaglutide use in this context is a key area of ongoing research, with further exploration into Semaglutide Use for Decreasing Hidradenitis Suppurativa resource utilization also underway.作者：M Hill·2025—Conclusion: The results suggest that HS patients on semaglutide demonstrate reduced HS severity. While the initial focus of semaglutide was on conditions like diabetes and weight loss, its application in dermatological disorders like hidradenitis suppurativa is proving to be a significant development in patient care. Though further research is essential, semaglutide certainly may offer a new lifeline for patients with hidradenitis suppurativa.